Dexcom (DXCM) Deferred Taxes (2010 - 2026)

Dexcom (DXCM) has reported Deferred Taxes for 17 consecutive years, with -$300000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 96.63% year-over-year to -$300000.0 in Q2 2026; TTM through Jun 2026 was $203.9 million, a 10295.0% increase from a year earlier, with the FY2025 full-year figure at $182.2 million, up 515.98% from the prior year.
• Deferred Taxes was -$300000.0 for Q2 2026 at Dexcom, down from $7.3 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $118.0 million in Q3 2025 and troughed at -$85.0 million in Q3 2023.
• A 5-year average of $3.8 million and a median of -$7.4 million in 2025 frame the typical range for Deferred Taxes.
• Across the five-year window, Deferred Taxes slumped 1289.47% in 2022 and surged 1117.24% in 2025, its largest moves.
• Over 5 years, Deferred Taxes stood at $32.0 million in 2022, then jumped by 154.69% to $81.5 million in 2023, then tumbled by 70.18% to $24.3 million in 2024, then soared by 224.69% to $78.9 million in 2025, then sank by 100.38% to -$300000.0 in 2026.
• The last three Deferred Taxes figures came in at -$300000.0 (Q2 2026), $7.3 million (Q1 2026), and $78.9 million (Q4 2025), per Business Quant data.